BridgeMD
New treatment option for Elderly (People Aged 65 or More)
Official title The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals
ClinicalTrials.gov ID: NCT07381166
What this study is testing
- What it's testing
- This study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- for the study:
- Age ≥ 65 years old
- Having at least basic literacy,
- Receiving metered-dose inhaler therapy for at least 6 months,
- Being hospitalized in the pulmonary ward,
You likely can't join if
- for the study:
- Age \<65
- Illiteracy
- Receiving metered-dose inhaler therapy for \<6 months
- Outpatient treatment
- Being hospitalized in the intensive care unit
See the full eligibility criteria
- for the study:
- Age ≥ 65 years old
- Having at least basic literacy,
- Receiving metered-dose inhaler therapy for at least 6 months,
- Being hospitalized in the pulmonary ward,
- Presenting to the pulmonary function test unit,
- Presenting to the pulmonary outpatient clinic,
- Signing the informed consent form for participation in the study,
- Having internet access and a mobile device with Android/iOS operating system,
- Being able to use a telephone,
- Having no communication barriers,
- Being able to use the inhaler without needing assistance,
- Making an error in at least one of the usage steps according to the MDI usage skills chart.
- for the study:
- Age \<65
- Illiteracy
- Receiving metered-dose inhaler therapy for \<6 months
- Outpatient treatment
- Being hospitalized in the intensive care unit
- Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy)
- Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy)
- Not signing the informed consent form for participation in the study
- Not having internet access and a mobile device with Android/iOS operating system
- Not having telephone skills
- Having communication barriers
- Requiring assistance while using the inhaler
- Not making any errors in the usage steps according to the MDI usage skills chart
- Wanting to withdraw from the study/withdrawing from participation during the research process
- Not completing the questionnaire
The study team makes the final eligibility decision.
Where it's taking place
- Çanakkale, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Çanakkale, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.